Hosted on MSN
MTVA: DA-1241 in Combination with Efruxifermin Shows Additive Hepatoprotective Effects in Mouse MASH Model…
DA-1241 in Combination with Efruxifermin Shows Enhanced Hepatoprotective Effects On June 21, 2025, MetaVia Inc. (NASDAQ:MTVA) announced the presentation of preclinical data for DA-1241, the company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results